Skip to main content

Advertisement

Log in

Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

  • Review
  • Published:
Neuropsychology Review Aims and scope Submit manuscript

Abstract

This article presents a review of studies that have investigated the neuropsychological effects of antiretroviral treatment (ART) for HIV-1 infection. It provides a brief overview of the era of monotherapy, dual-therapy, and an extended overview of the current era of combination antiretroviral therapy (CART). This review highlights that while CART has had a dramatic effect on the incidence and the severity of HIV-associated neurocognitive disorders (HAND), HAND, in its mild form, still remains prevalent. New causes of this sustained prevalence are poor CNS penetration of some antiretroviral agents, drug resistance, poor adherence, potential neurotoxicity, co-morbidities such as the long-term CART side effects in relation to cardio-vascular disease, and chronic HIV brain infection that may facilitate the expression of new forms of neurodegenerative processes. The review emphasizes the need to address methodological limitations of published studies and the need for large and representative cross-disciplinary longitudinal investigations across the HIV illness span.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • American Academy of Neurology, & Dana Consortium. (1996). Clinical confirmation of the American academy of neurology algorithm for HIV-1-associated cognitive/motor disorder (Dana Consortium on therapy for HIV dementia and related cognitive disorders). Neurology, 47, 1247–1253.

    Google Scholar 

  • Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799.

    Article  CAS  PubMed  Google Scholar 

  • Arendt, G., von Giesen, H.-J., Hefter, H., & Theisen, A. (2001). Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection. AIDS, 15, 493–500.

    Article  CAS  PubMed  Google Scholar 

  • Ayers, M., Abrams, D., Newell, T., & Frieddrich, F. (1987). Performance of individuals with AIDS on the Luria-Nebraska Neuropsychological Battery. The International Journal of Clinical Neuropsychology, 9(3), 101–104.

    Google Scholar 

  • Baldeweg, T., Catalan, J., Lovett, E., Gruzelier, J., Riccio, M., & Hawkins, D. (1995). Long-term Zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS, 9, 589–596.

    Article  CAS  PubMed  Google Scholar 

  • Bangsberg, D. R. (2008). Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. Journal of Infectious Diseases, 197(Suppl 3), S272–278.

    Article  PubMed  Google Scholar 

  • Bangsberg, D. R., Kroetz, D. L., & Deeks, S. G. (2007). Adherence-resistance relationships to combination HIV antiretroviral therapy. Current HIV/AIDS Reports, 4(2), 65–72.

    Article  PubMed  Google Scholar 

  • Berger, J. R., & Avison, M. (2004). The blood brain barrier in HIV infection. Frontiers Biosciences, 9, 2680–2685.

    Article  CAS  Google Scholar 

  • Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., et al. (2008). Changes in the incidence and predictors of Human Immunodeficiency Virus-associated Dementia in the era of highly active antiretroviral therapy. Annals of Neurology, 63(2), 213–221.

    Article  PubMed  Google Scholar 

  • Brew, B. J. (2001). Markers of AIDS Dementia Complex: The role of cerebrospinal fluid assays. AIDS, 15(14), 1883–1884.

    Article  CAS  PubMed  Google Scholar 

  • Brew, B. J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS Dementia Complex. AIDS, 18(suppl 1), S75–S78.

    CAS  PubMed  Google Scholar 

  • Brew, B. J. (2007). Lost in translation: again, another failed neuroprotection trial. Neurology, 69(13), 1308–1309.

    Article  PubMed  Google Scholar 

  • Brew, B. J., Halman, M., Catalan, J., Sacktor, N., Price, R. W., Brown, S., et al. (2007). Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial. PLoS Clinical Trials, 2(3), e13.

    Article  PubMed  CAS  Google Scholar 

  • Brew, B., Crowe, S. M., Landay, A., Cysique, L., & Guillemin, G. (2008). Neurodegeneration and Ageing in the HAART Era. Journal of Neuroimmune Pharmacology, 6, 6.

    Google Scholar 

  • Brouwers, P., Hendricks, M., Lietzau, J. A., Pluda, J. M., Mitsuya, H., Broder, S., et al. (1997). Effect of combination therapy with zidovudine and didanosine on neuropsychological functionning in patients with symptomatic HIV disease: A comparison of simultaneous and alternating regimens. AIDS, 11, 59–66.

    Article  CAS  PubMed  Google Scholar 

  • Center for Diseases Control [CDC]. (1993). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mortality and Morbidity Weekly Report, 41, No. RR-17.

  • Cherry, C. L., Lala, L., & Wesselingh, S. L. (2005). Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management. Sexual Health, 2(1), 1–11.

    Article  PubMed  Google Scholar 

  • Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17(4), 169–177.

    Article  PubMed  Google Scholar 

  • Childers, M. E., Woods, S. P., Letendre, S., McCutchan, J. A., Rosario, D., Grant, I., et al. (2008). Cognitive functioning during highly active antiretroviral therapy interruption in Human Immunodeficiency Virus type-1 infection. Journal of Neurovirology, 18, 1–8.

    Google Scholar 

  • Clifford, D. B., McArthur, J. C., Schifitto, G., Kieburtz, K., McDermott, M. P., Letendre, S., et al. (2002). A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology, 59(10), 1568–1573.

    CAS  PubMed  Google Scholar 

  • Cohen, R., Boland, R., Paul, R., Tashima, K. T., Schoenbaum, E. E., Celentano, D. D., et al. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15, 341–345.

    Article  CAS  PubMed  Google Scholar 

  • Cole, M. A., Margolick, J. B., Cox, C., Li, X., Selnes, O. A., Martin, E. M., et al. (2007). Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology, 69(24), 2213–2220.

    Article  CAS  PubMed  Google Scholar 

  • Cunningham, P., Smith, D., Satchell, C., Cooper, D. A., & Brew, B. (2000). Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS, 14, 1949–1954.

    Article  CAS  PubMed  Google Scholar 

  • Cysique, L., & Brew, B. (2009). The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era. In R. Paul, N. Sacktor, V. Valcour & K. Tashima (Eds.), HIV and the Brain: New Challenges in the Modern Era. Totowa, NJ: Humana Press Inc.

    Google Scholar 

  • Cysique, L., Maruff, P., & Brew, B. (2004a). Antiretroviral therapy in HIV infection: are neurologically active drugs important? Archives of Neurology, 61(11), 1699–1704.

    Article  PubMed  Google Scholar 

  • Cysique, L., Maruff, P., & Brew, B. (2004b). Prevalence and pattern of neuropsychological impairment in HIV/AIDS-infection across pre and post- Highly Active Antiretroviral Therapy eras: a combined study of 2 cohorts. Journal of Neurovirology, 10, 350–357.

    Article  PubMed  Google Scholar 

  • Cysique, L., Maruff, P., & Brew, B. (2006a). The neuropsychological profile of symptomatic, AIDS and ADC patients in the pre-HAART era: a meta-analysis. Journal of the International Neuropsychological Society, 12, 1–15.

    Article  Google Scholar 

  • Cysique, L. A., Maruff, P., & Brew, B. J. (2006b). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 1447–1450.

    Article  PubMed  Google Scholar 

  • Cysique, L., Vaida, F., Letendre, S., Gibson, S., Woods, S., Cherner, M., et al. (in press). Dynamics of cognitive change in impaired HIV + individuals initiating antiretroviral therapy. Neurology.

  • Deeks, S. G., Wrin, T., Liegler, T., Hoh, R., Hayden, M., Barbour, J. D., et al. (2001). Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. New England Journal of Medicine, 344(7), 472–480.

    Article  CAS  PubMed  Google Scholar 

  • Dore, G. J., McDonald, A., Li, Y., Kaldo, J. M., & Brew, B. J. (2003). Marked improvement in survival following AIDS Dementia Complex in the era of highly active antiretroviral therapy. AIDS, 17, 1539–1545.

    Article  PubMed  Google Scholar 

  • El-Sadr, W. M., Lundgren, J. D., Neaton, J. D., Gordin, F., Abrams, D., Arduino, R. C., et al. (2006). CD4 + count-guided interruption of antiretroviral treatment. New England Journal of Medicine, 355(22), 2283–2296.

    Article  CAS  PubMed  Google Scholar 

  • Enting, R., Hoetelmans, R., Lange, J., Burger, D. M., Beijnen, J. H., & Portegies, P. (1998). Antiretroviral drugs and the central nervous system. AIDS, 12, 1941–1953.

    Article  CAS  PubMed  Google Scholar 

  • Evans, S. R., Yeh, T. M., Sacktor, N., Clifford, D. B., Simpson, D., Miller, E. N., et al. (2007). Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials, 8(6), 437–446.

    Article  PubMed  Google Scholar 

  • Ferrando, S., Van Gorp, W., McElhiney, M., Goggin, K., Sewell, M., & Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS, 12(8), F65–F70.

    Article  CAS  PubMed  Google Scholar 

  • Ferrando, S. J., Rabkin, J. G., van Gorp, W. G., Lin, S.-H., & McElhiney, M. (2003). Longitudinal improvement in psychomotor processing is associated with potent antiretroviral therapy in HIV-1 infection. Journal of Neuropsychiatry and Clinical Neurosciences, 15(2), 208–214.

    PubMed  Google Scholar 

  • Gao, P., Ware, J. H., & Mehta, C. (2008). Sample size re-estimation for adaptive sequential design in clinical trials. Journal of Biopharmaceutical Statistics, 18(6), 1184–1196.

    Article  PubMed  Google Scholar 

  • Gimenez, F., Fernandez, C., & Mabondzo, A. (2004). Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins. Journal of Acquired Immune Deficiency Syndrome, 36(2), 649–658.

    Article  CAS  Google Scholar 

  • Gray, F., Bazille, C., Adle-Biassette, H., Mikol, J., Moulignier, A., & Scaravilli, F. (2005). Central nervous system immune reconstitution disease in Acquired Immunodeficiency Syndrome patients receiving highly active antiretroviral treatment. Journal of Neurovirology, 11(Suppl 3), 16–22.

    Article  PubMed  Google Scholar 

  • Heaton, R., Temkin, N., Dikmen, S., Avitable, N., Taylor, M., Marcotte, T., et al. (2001). Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Archives of Clinical Neuropsychology, 16(1), 75–91.

    CAS  PubMed  Google Scholar 

  • Heaton, R. K., Cysique, L. A., Jin, H., Shi, C., Yu, X., Letendre, S., et al. (2008). Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. Journal of Neurovirology, 7, 1–14.

    Google Scholar 

  • Hedeker, D., & Gibbons, R. D. (2006). Longitudinal Data Analysis. Hoboken, NJ: Wiley.

    Google Scholar 

  • Hightower, G., Letendre, S., Cherner, M., Gibson, S., Ellis, R., Ignacio, C., et al. (2008). ART Resistance Influences CSF HIV RNA Levels and Neuropsychological Performance in HIV-infected Individuals Poster presented at the 15th Conference on Retroviruses and Opportunistic Infections, February 3-6.

  • Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002). Medication adherence among HIV + adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944–1950.

    CAS  PubMed  Google Scholar 

  • Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: effect of patient age, cognitive status and substance. AIDS, 18(suppl 1), S19–S25.

    PubMed  Google Scholar 

  • Lekakis, J., Tsiodras, S., Ikonomidis, I., Palios, J., Poulakou, G., Rallidis, L., et al. (2008). HIV positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease. Clinical Science (London, England), 5, 5.

  • Letendre, S., Marquie-Beck, J., Capparelli, E., Best, B., Clifford, D., Collier, A. C., et al. (2008). Validation of the CNS penetration-effectiveness rank for qualifying antiretroviral penetration into the central nervous system. Archives of Neurology, 65(1), 65–70.

    Article  PubMed  Google Scholar 

  • Letendre, S., McCutchan, J., Childers, M., Woods, S., Lazzaretto, D., Heaton, R., et al. (2004). Enhancing antiretroviral therapy for Human Immunodeficiency Virus cognitive disorders. Annals of Neurology, 56(3), 416–423.

    Article  PubMed  Google Scholar 

  • Lewis, W. (2005). Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antiviral Therapy, 10(Suppl 2), M13–27.

    CAS  PubMed  Google Scholar 

  • Llorente, A. M., van Gorp, W. G., Stern, M. J., George, L., Satz, P., Marcotte, T. D., et al. (2001). Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: results of a randomized, double-blind, placebo-controlled investigation. Journal of the International Neuropsychological Society, 7, 27–32.

    Article  CAS  PubMed  Google Scholar 

  • Marra, C. M., Lockhart, D., Zunt, J. R., Perrin, M., Coombs, R. W., & Collier, A. C. (2003). Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology, 60, 1388–1390.

    CAS  PubMed  Google Scholar 

  • May, S., Letendre, S., Haubrich, R., McCutchan, J. A., Heaton, R., Capparelli, E., et al. (2007). Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. Journal of Neuroimmune Pharmacology, 2(1), 97–104.

    Article  PubMed  Google Scholar 

  • McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S., et al. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109–1117.

    Article  PubMed  Google Scholar 

  • Miller, V., & Larder, B. A. (2001). Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure. Antiviral Therapy, 6(Suppl 3), 25–44.

    PubMed  Google Scholar 

  • Mollica, C., Maruff, P., & Vance, A. (2004). Development of a statistical approach to classifying treatment response in individual children with ADHD. Human Psychopharmacology, 19(7), 445–456.

    Article  PubMed  Google Scholar 

  • Pialoux, G., Fournier, S., Moulignier, A., Poveda, J., Clavel, F., & Dupont, B. (1997). Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS, 11(10), 1302–1303.

    CAS  PubMed  Google Scholar 

  • Piccinini, M., Rinaudo, M. T., Anselmino, A., Buccinna, B., Ramondetti, C., Dematteis, A., et al. (2005). The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function. Antiviral Therapy, 10(2), 215–223.

    CAS  PubMed  Google Scholar 

  • Rabbitt, P., Diggle, P., Holland, F., & McInnes, L. (2004). Practice and drop-out effects during a 17-year longitudinal study of cognitive aging. Journal of Gerontology Psychological Sciences, 59B(2), 84–97.

    Google Scholar 

  • Reinvang, I., Froland, S., Karlsen, N., & Lundervold, A. (1991). Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine. AIDS, 5(2), 228–229.

    Article  CAS  PubMed  Google Scholar 

  • Riedel, D. J., Pardo, C. A., McArthur, J., & Nath, A. (2006). Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nature Clinical Practice Neurology, 2(10), 557–565.

    Article  PubMed  Google Scholar 

  • Roberston, K., Roberston, T. W., Ford, S., Watson, D., Fiscus, S., Harp, A. G., et al. (2004). Highly Active Antiretroviral Therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndrome, 36(1), 562–566.

    Article  Google Scholar 

  • Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., et al. (2007a). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915–1921.

    Article  Google Scholar 

  • Roberston, K., Su, Z., Krambrink, A., Evans, S. R., Havlir, D., Margolis, D., et al. (2007b). This Is Your Brain off Drugs: Neurocognitive Function before and after ART Discontinuation in Patients with High CD4 Nadir (ACTG A5170). Paper presented at the 14th Conference on Retroviruses and Opportunistic Infections February 25 -February 28.

  • Sacktor, N. C., Bacellar, H., Hoover, D. R., Nance-Sproson, T. E., Selnes, O. A., Miller, E. N., et al. (1996). Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. Journal of Neurovirology, 2, 404–410.

    Article  CAS  PubMed  Google Scholar 

  • Sacktor, N. C., Lyles, R. H., Skolasky, R. L., Anderson, D. E., McArthur, J. C., McFarlane, G., et al. (1999). Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Neurology, 52, 1640–1647.

    CAS  PubMed  Google Scholar 

  • Sacktor, N., McDermott, M., Marder, K., Schifitto, G., Selnes, O. A., McArthur, J. C., et al. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136–142.

    Article  PubMed  CAS  Google Scholar 

  • Sacktor, N., Skolasky, R. L., Tarwater, P. M., McArthur, J. C., Selnes, O. A., Becker, J., et al. (2003). Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology, 61, 567–569.

    CAS  PubMed  Google Scholar 

  • Sacktor, N., Nakasujja, N., Skolasky, R., Robertson, K., Wong, M., Musisi, S., et al. (2006). Antiretroviral therapy improves cognitive impairment in HIV + individuals in sub-Saharan Africa. Neurology, 67(2), 311–314.

    Article  CAS  PubMed  Google Scholar 

  • Schaie, K. W., & Hofer, S. M. (2001). Handbook of the Psychology of Aging. In K. W. Schaie & J. E. Birren (Eds.), Longitudinal studies in aging research (5th ed.). San Diego: Academic Press.

    Google Scholar 

  • Schifitto, G., Navia, B. A., Yiannoutsos, C. T., Marra, C. M., Chang, L., Ernst, T., et al. (2007a). Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS, 21(14), 1877–1886.

    Article  CAS  Google Scholar 

  • Schifitto, G., Zhang, J., Evans, S. R., Sacktor, N., Simpson, D., Millar, L. L., et al. (2007b). A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology, 69(13), 1314–1321.

    Article  CAS  Google Scholar 

  • Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., et al. (1988). Neuropsychological outcome of Zidovudine (AZT) treatment fo patients with AIDS and AIDS related-complex. New England Journal of Medicine, 319, 1573–1578.

    Article  CAS  PubMed  Google Scholar 

  • Schweinsburg, B. C., Taylor, M. J., Alhassoon, O. M., Gonzalez, R., Brown, G. G., Ellis, R. J., et al. (2005). Brain mitochondrial injury in Human Immunodeficiency Virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol, 11(4), 356–364.

    Article  CAS  PubMed  Google Scholar 

  • Sidtis, J. J., Gatsonis, C., Price, R. W., Singer, E. J., Collier, A. C., Richman, D. D., et al. (1993). Zidovudine treatment of the AIDS Dementia Complex: results of a placebo-controlled trial. Annals of Neurology, 33, 343–349.

    Article  CAS  PubMed  Google Scholar 

  • Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10(3), 227–245.

    Article  PubMed  Google Scholar 

  • Smit, T. K., Brew, B. J., Tourtellotte, W., Morgello, S., Gelman, B. B., & Saksena, N. K. (2004). Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology, 78(18), 10133–10148.

    Article  CAS  PubMed  Google Scholar 

  • Strain, M. C., Letendre, S., Pillai, S. K., Russell, T., Ignacio, C. C., Gunthard, H. F., et al. (2005). Genetic composition of Human Immunodeficiency Virus type-1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology, 79(3), 1772–1788.

    Article  CAS  PubMed  Google Scholar 

  • Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetski, C., et al. (2001). Outcome of patients with HIV-1 related cognitive impairment on highly active antiretroviral therapy. AIDS, 15, 192–200.

    Article  Google Scholar 

  • Sullivan, E. V., Adalsteinsson, E., Spielman, D. M., Hurd, R. E., & Pfefferbaum, A. (2001). N-acetylaspartate–a marker of neuronal integrity. Annals of Neurology, 50(6), 823.

    Article  CAS  PubMed  Google Scholar 

  • Tozzi, V., Narciso, P., & Calgani, S. (1993). Effects of Zidovudine in 30 patients with mild to end-stage AIDS Dementia Complex. AIDS, 7, 638–692.

    Article  Google Scholar 

  • Tozzi, V., Balestra, P., Galgani, S., Narciso, P., Ferri, F., Sebastiani, G., et al. (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1 associated neurocognitive impairment. AIDS, 13, 1889–1897.

    Article  CAS  PubMed  Google Scholar 

  • Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Visco-Comandini, U., et al. (2007). Persistence of neuropsychological deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. Journal of Acquired Immune Deficiency Syndrome, 45(2), 174–182.

    Article  Google Scholar 

  • U.S. Food and Drug Administration [FDA]. (2008). Drugs Used in the Treatment of HIV Infection. Retrieved November 2008 <http://www.fda.gov/oashi/aids/virals.html >

  • Valcour, V., & Paul, R. (2006). HIV infection and dementia in older adults. Clinical Infectious Diseases, 42(10), 1449–1454.

    Article  PubMed  Google Scholar 

  • Valcour, V., Yee, P., Williams, A. E., Shiramizu, B., Watters, M., Selnes, O., et al. (2006a). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection–The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387–391.

    Article  Google Scholar 

  • Valcour, V. G., Sacktor, N. C., Paul, R. H., Watters, M. R., Selnes, O. A., Shiramizu, B. T., et al. (2006b). Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging with HIV cohort. Journal of Acquired Immune Deficiency Syndrome, 43(4), 405–410.

    Article  Google Scholar 

  • Venkataramana, A., Pardo, C. A., McArthur, J. C., Kerr, D. A., Irani, D. N., Griffin, J. W., et al. (2006). Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology, 67(3), 383–388.

    Article  CAS  PubMed  Google Scholar 

  • Venturi, G., Catucci, M., Romano, L., Corsi, P., Leoncini, F., Valensin, P. E., et al. (2000). Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. The Journal of Infectious Diseases, 181, 740–745.

    Article  CAS  PubMed  Google Scholar 

  • Verbiest, W., Brown, S., Cohen, C., Conant, M., Henry, K., Hunt, S., et al. (2001). Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study. AIDS, 15(5), 647–650.

    Article  CAS  PubMed  Google Scholar 

  • White, D. A., Heaton, R., & Monsch, A. U. (1995). Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-type-1 infected individuals. Journal of the International Neuropsychological Society, 1, 304–315.

    Article  CAS  PubMed  Google Scholar 

  • Woods, S. P., Moran, L. M., Carey, C. L., Dawson, M. S., Iudicello, J. E., Gibson, S., et al. (2008). Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Archives of Clinical Neuropsychology, 23(3), 257–270.

    Article  PubMed  Google Scholar 

  • Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology, 71(1), 50–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lucette A. Cysique.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cysique, L.A., Brew, B.J. Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review. Neuropsychol Rev 19, 169–185 (2009). https://doi.org/10.1007/s11065-009-9092-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11065-009-9092-3

Keywords

Navigation